Filing Details
- Accession Number:
- 0001127602-19-001139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-04 13:48:51
- Reporting Period:
- 2019-01-02
- Accepted Time:
- 2019-01-04 13:48:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000697 | Waters Corp | WAT | Laboratory Analytical Instruments (3826) | 133668640 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1186877 | J Michael Berendt | 34 Maple Street Milford MA 01757 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-02 | 3,500 | $38.09 | 27,411 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-02 | 3,500 | $184.74 | 23,911 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-01-02 | 599 | $0.00 | 24,510 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-01-02 | 3,500 | $0.00 | 3,500 | $38.09 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-01-02 | 1,760 | $0.00 | 1,760 | $183.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-01-02 | 2019-01-02 | No | 4 | M | Direct |
| 1,760 | 2020-01-02 | 2029-01-02 | No | 4 | A | Direct |
Footnotes
- Acquisition of common stock was made under a sale plan established pursuant to the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Sale of common stock was made under a sale plan established pursuant to the requirements of Rule 10b5-1 under the Securities and Exchange Act of 1934, as amended.
- Grant of shares of common stock subject to restrictions that lapse January 2, 2020.
- Options fully vest on January 2, 2020.
Billionaire Hedge Funds
